Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OIG Cautions Manufacturers On Group Purchasing Organization "Prebates"

This article was originally published in The Gray Sheet

Executive Summary

Group purchasing organizations and medical device vendors may be subject to prosecution under the federal anti-kickback statute if they make agreements with substantial "up-front" payments, according to the HHS Office of Inspector General.

You may also be interested in...



MDMA, GPOs May Reopen Dialogue Before Senate Hearings This Spring

The Medical Device Manufacturers Association plans to meet with Premier, Novation and the Health Industry Group Purchasing Association prior to an upcoming Senate Judiciary/Antitrust, Business Rights and Competition Subcommittee hearing on group purchasing organization practices, tentatively scheduled for April 10

MDMA, GPOs May Reopen Dialogue Before Senate Hearings This Spring

The Medical Device Manufacturers Association plans to meet with Premier, Novation and the Health Industry Group Purchasing Association prior to an upcoming Senate Judiciary/Antitrust, Business Rights and Competition Subcommittee hearing on group purchasing organization practices, tentatively scheduled for April 10

GPO Administrative Fees Fall Within Safe Harbor Provision, OIG Concludes

A May 22 HHS Office of the Inspector General advisory opinion supports administrative fees as long as they meet group purchasing organization (GPO) safe-harbor requirements.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013678

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel